Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Confe... ( ADDISON Texas April 1 /- ULURU .....)

HOME >> MEDICINE >> NEWS

Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009

Date:4/1/2009

ADDISON, Texas, April 1 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced today that clinical evidence on the treatment of wounds using Altrazeal(TM) Transforming Powder Dressing, and data on the physical properties of Altrazeal(TM) Silver will be presented at the annual APWCA National Clinical Conference in Philadelphia, April 2-5, 2009. The work will be presented in podium presentations and with posters on display during the meeting.

Renaat Van den Hooff, President and CEO of ULURU Inc., commented: "Since the launch of Altrazeal(TM) in June 2008, we have accumulated extensive clinical experience across all wound types. The presentation of this data in a formal forum is a reflection of the execution of an important part of our 2009 business strategy."

Dr. Brock Liden, DPM of the Berger Health Care Center in Circleville, Iowa, will discuss at one podium presentation a talk titled "Treatment methods and experience with a novel aggregating powder dressing." In this presentation, Dr. Liden will detail his experiences and best clinical practice using Altrazeal(TM), application techniques, and what to expect when applying and treating wounds with the dressing.

In addition, clinical evidence using Altrazeal(TM) in treatment of diabetic foot ulcers, surgical wounds, and difficult to treat wounds such as those on sickle cell patients or patients afflicted with lymphangioma or pyoderma will be presented. A total of five posters detailing clinical evidence of Altrazeal(TM) will be displayed including one that shows the successful use of Altrazeal(TM) under contact casts in the treatment of diabetic foot ulcers. Commenting on the product, Dr. Greg Bohn, MD, FACS, Medical Director of the Trinity Center for Wound Care and Hyperbaric Medicine in Bettendorf, Iowa, and author of three of the posters stated, "Altrazeal(TM) is proving to be a very versatile dress
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. ULURU Inc. Announces the Launch of the Altrazeal(TM) Website
2. ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
3. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
4. Upcoming Symposium to Bridge the Gap between Osteoporosis Research and its Applications to Clinical Practice with Focus on Secondary Osteoporosis, Osteoporosis in Men, and Lessons from Space Travel for Improving Bone Health
5. By shutting down inflammation, agent reverses damage from spinal cord injury in preclinical studies
6. Australian clinical trials threatened: Jobs and patient access to new treatments at stake
7. Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
8. Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology
9. Task Force Recommends Screening Adolescents for Clinical Depression
10. Hard to Treat Diseases (HTDS) clinical trial protocol for MMR Vaccine expected Q2 2009
11. Catastrophic Head and Neck Injuries Among Focus for NFL Team Physicians and Clinical Staff at Fourth Annual Injuries in Football Conference

Post Your Comments:

Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Confe...( ADDISON Texas April 1 /- ULURU .....),Health